A visual breakdown of how predictive extractables and leachables (E&L) testing with AI-powered modeling with Lumo™ eliminates response factor variation to deliver faster, more defensible chemical characterization for medical devices and combination products. 

You’ll Learn How Lumo™ Helps: 

  • Predict compound-specific response factors using neural networks 
  • Reduce unnecessary calibrations and lower AET-triggered burdens 
  • Accelerate ISO 10993-18 compliant workflows with fewer “unknowns” 
  • Improve submission defensibility and reduce Additional Information (AI) requests 
  • Cut lab timelines from 22 weeks to as little as 4 weeks in select programs 

Who Should Read:

  • MedTech manufacturers and combination product developers navigating ISO 10993-18, chemical characterization, or E&L compliance 
  • Regulatory, Quality, and Lab leaders 
  • Preclinical, Product Development, Clinical Affairs, and Program Management teams who are responsible for submission strategy, testing timelines, or toxicology defensibility 

The Outcome:  

A predictive, lab-to-toxicology blueprint that reduces E&L uncertainty, accelerates chemical characterization, and strengthens submission confidence. 

Download the infographic to see how smarter predictions mean faster programs. 

Back to Resources

Get Your Copy Now

Fields marked with * are required.

Your ideas make an impact. Our expertise brings them to life.

Choose RQM+ as your partner and let’s make MedTech happen together.

Contact Us Today